Targeted binging agents directed to KDR and uses thereof - 035

Details for Australian Patent Application No. 2008278803 (hide)

Owner AstraZeneca AB

Inventors Barry, Simon Thomas; Zhou, Qing; Kang, Jaspal Singh; Bedian, Vahe; Hedberg, Bradley

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008278803

PCT Pub. Number WO2009/013543

Priority 60/951,805 25.07.07 US

Filing date 23 July 2008

Wipo publication date 29 January 2009

International Classifications

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/013543 Priority application(s): WO2009/013543

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008278808-A sampling device

2008278801-An adduct of 1-hydroxyethylidene-l, 1diphosphonic acid and ethylened iamine disuccinic acid or a salt thereof, a method for its preparation, and the use of said adduct